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Abstract 
Purpose: Heart rate variability threshold (HRVT) is a clinical parameter used to gain insight into 
autonomic balance. Various studies have validated the use of cycle ergometers in determining 
HRVT, although the literature lacks evidence that treadmill use is a viable means of determining 
this threshold. We examined the repeatability of HRVT occurrence using standard deviation of 
normal R-R intervals (SDNN), root mean square of successive differences of continuous R-R 
intervals (RMSSD), and standard deviation of instantaneous beat intervals (SD1) in college aged 
males using treadmill exercise to see if this is a reliable method of threshold determination. 
Methods: Ten healthy, college-aged males underwent two treadmill max tests while heart rate 
and ventilation data was obtained using a polar V-800 watch and a PARVO metabolic cart, 
respectively. Paired t-tests were used to compare consistency of average HRVT and VT 
occurrence between trials, and to find agreement of HRVT and VT occurrence together within 
trials. 
Results: There was no difference between SDNN, RMSSD, SD1, or VT occurrence between 
trials one and two. There a significant difference between RMSSD and VT and SD1 and VT (P = 
0.003 and 0.002, respectively), however there was agreement between SDNN and VT (P = 0.06).  
Conclusion:  Treadmill modality is a reliable method of finding HRVT in a population of 
healthy young males. HRVT and VT does not correspond on a treadmill as it has been reported 
to with cycle ergometry.  
 
 
Keywords: Heart rate variability threshold, treadmill, reliability 
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Chapter I 
Introduction 
The heart is a vital organ which is involved in the delivery of blood to the various organs 
and tissues of the body. The heart has two groups of muscle cells: autorhythmic and contractile. 
The contractile cells are those that undergo mechanical contraction that result in atrial and 
ventricular contraction, which physically pumps the blood. The autorhythmic or pacemaker cells 
of the heart are responsible for exciting the contractile cells at a certain rate, which leads the 
observable phenomenon of heart rate. These autorhythmic cells are grouped into various nodes, 
allowing for signal transmission to be delivered to each part of the heart. The atrioventricular 
(AV) node is found in the interatrial septum, and the sinoatrial (SA) node is found in the right 
atrium. Heart rate can vary drastically dependent on various environmental or physiological 
conditions; this large range is the result of sympathetic and parasympathetic input from the 
nervous system. Sympathetic nerve fibers synapse with the SA and AV nodes to increase heart 
rate, and with the contractile cells of the ventricles to increase force of ventricular contraction. 
Parasympathetic nerve fibers synapse with the SA and AV node to slow the heart rate (1).  
 
The autorhythmic cells send electrical impulses to the contractile cells to initiate 
contraction in different regions of the heart. These electrical impulses can be represented 
graphically with an electrocardiogram (EKG), and can be indicative of the mechanical work that 
is being done in the heart at a given time. The P-wave in an EKG graph represents atrial 
depolarization, which translates to atrial contraction. The QRS complex is an easily identifiable 
spike that represents ventricular depolarization, indicative of ventricular contraction. The last 
major event, the T-wave, represents ventricular repolarization (2). The largest, most identifiable 
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part of the QRS complex is the R-wave. The distance between two R-waves (two ventricular 
contractions) is the R-R interval. The R-R interval can be used to calculate heart rate, but can 
also be used for other biomarkers that can have clinical and sports-related significance. One of 
these biomarkers is known as heart rate variability. Heart rate variability if the deviation of time 
between R-R intervals, or heart beats. These deviations are the result of regulatory mechanisms 
of the body that control heart rate, and the frequency that these stimuli are applied to the heart. 
The heart is extensively regulated by both the sympathetic and parasympathetic components of 
the autonomic nervous system. The sympathetic nervous system releases catecholamines, which 
increase the rate of SA node depolarization, while the parasympathetic nervous system releases 
acetylcholine which slows the rate of SA node depolarization (1). The frequency that these 
inputs regulate heart rate create the phenomena of heart rate variability.  
 
Sympathetic and parasympathetic input innervate the heart at different frequencies. These 
bands of frequency can be divided into ultra-low frequencies (ULF), thought to be the product of 
the circadian rhythm; very low frequencies (VLF), thought to be the product of temperature and 
endocrine regulation; low frequencies (LF), believed to be the product of both sympathetic and 
parasympathetic input; and high frequencies (HF), thought to be due to parasympathetic input 
and respiratory sinus arrhythmia (3, 4). For the purposes of this study, high and low frequency 
bands were emphasized. The HF band is found between .15 and .4 Hz, while the LF band is 
found between .04 and .15 Hz. Examining the presence or absence of these frequency bands via 
power spectral analysis is known as a frequency-domain analysis of HRV. Alternative ways to 
measure HRV are time-domain analysis. SDNN (the standard deviation of normal R-R intervals) 
is one method of time-domain analysis, which focuses on the standard deviation of R-R intervals. 
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RMSSD (root mean square of successive differences) is another time domain method of HRV 
analysis which is primarily used for short term HRV recordings (5). 
 
HRV is generally high at rest in healthy individuals, and decreases with increasing 
exercise intensity because of increased sympathetic stimulation and parasympathetic withdrawal. 
HRV can also decrease due to chronic disease, increasing age, psychological stress, and other 
variables that will be discussed further. Heart rate variability is known to be the product of the 
balance between sympathetic and parasympathetic inputs, with parasympathetic input producing 
greater beat to beat variations than its counterpart due to the immediate effect of parasympathetic 
neurotransmitters versus the relatively tonic effect of sympathetic neurotransmitters (6, 2). 
Bonnemeier et al. found that HRV is associated with an individual’s circadian rhythm, with peak 
vagal activity and higher levels of HRV occurring at night (7). Bonnemeier et al. also found that 
increasing age is associated with decreased HRV peaks during the circadian rhythm, presumably 
due to a decrease in parasympathetic activity at night. However, the circadian-dependent HRV 
cycles where HRV increases at night are based on reduced levels of sympathetic input during the 
night, not due to an increase in vagal tone (8). Not only do demographics and health status 
influence HRV, but emotional status does as well. Thayer et al. found that amygdala activity, a 
regulatory center of the brain associated with fear and threat perception also plays a role in 
controlling HRV, suggesting a linkage between stress and HRV presumably due to autonomic 
influence (9). The emotional stress-HRV relationship is further supported by Dikecligil et al, 
who found that emotional stress was directly related to a decrease in HRV (10). These principles 
are important to consider when assessing HRV to prevent transient stress from being 
misinterpreted as poor health.  
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Heart rate variability is an important biomarker which gives insight into an individual’s 
autonomic functioning. This variable can be used clinically, as well as give insight into one’s 
stress and mental health. HRV is a minimally invasive, low cost procedure that can assist in 
detecting and predicting cardiovascular disease, the leading killer in the United States. Tsuji 
found that in 2501 otherwise healthy men and women, HRV was a strong predictor of future 
coronary disease or congestive heart failure (11). Tsuji et al. also found in a previous study that 
in an elderly population, low levels of HRV is indicative of high levels of all-cause mortality, 
further bolstering the clinical significance of HRV (12). Seeing as the relationship between HRV 
and age is known, Umetai et al. supplemented this knowledge with a study that showed that not 
only does HRV decrease with age, but falls into a range that may classify otherwise healthy 
individuals greater than 65 years old to be at a heightened risk of all-cause mortality (13). 
However, HRV is susceptible to change with an exercise intervention. Previous literature 
supports the notion that resting HRV can increase with physical activity, presumably due to an 
increase in parasympathetic activity which increases the magnitude of respiratory-sinus induced 
HRV (14). Bär et al. demonstrated that an exercise intervention not only increased resting HRV 
levels, but also increases vagal activity at a given intensity during exercise (15). Stein et al. also 
showed that in a group of older individuals, an exercise intervention lead to higher levels of 
resting HRV than a non-intervention group (16). 
 
Heart rate variability is a tool that can not only be used clinically, but may also give 
insight into other physiological processes associated with athletic performance. HRV decreases 
as exercise intensity increases due to sympathetic increase and vagal withdraw, but there is a 
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threshold that occurs when vagal activity is totally withdrawn, and the R-R interval variability 
remains constant. This occurrence is termed the heart rate variability threshold (HRVT). 
Dourado et al. stated that at roughly 50-60% of VO2max, vagal activity is totally withdrawn, and 
all resulting changes in HRV is the result of varying levels of sympathetic stimulation (17). 
HRVT is also commonly found around the same intensity as lactate threshold (LT) and 
ventilatory threshold (VT) (18). VT is marked by a disproportionate increase in ventilation (VE) 
compared to VO2 (19). Beaver et al. determined that anaerobic threshold is indicative of the 
bicarbonate buffering system maintaining a steady state blood pH, which generally occurs during 
the transition to primarily anaerobic metabolism. The bicarbonate buffering system causes a 
disproportionate increase in VCO2 relative to VO2, which is an observable phenomenon known 
as the ventilatory threshold or gas exchange threshold (GET) (20). LT occurs at roughly 60% of 
an untrained individual’s VO2max when lactate production exceeds lactate clearance (21). One 
contributing factor to LT is the increase of plasma catecholamine concentration as both exercise 
duration and intensity increases (22). These neurotransmitters serve to decrease HRV as well as 
increase the production of lactate by stimulating glycolysis, as well as decreasing the blood flow 
to the liver, limiting lactate clearance via gluconeogenesis (23). High levels of lactate are 
registered by chemoreceptors in the carotid artery, stimulating an increase in VE which may be a 
contributing factor as to why VT and LT often happen around the same intensity (24, 25). 
Several studies have shown the relationship for HRVT and these two thresholds. Anosov et al. 
found that the HRVT also occurred at the same intensity as the anaerobic threshold, or the shift 
to primarily anaerobic metabolism indicated by LT and VT (26). Karapetian et al. found that 
HRVT occurred at roughly the same intensity as LT (18). Additionally, Cunha et al. studied the 
relationship between HRVT and VT, and found that there was a strong relationship between 
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HRVT and the VT in both running and cycling modalities (27). The use of HRVT to detect LT 
and VT adds convenience for both the practitioner and client in detecting these important 
physiological occurrences. LT and VT are two variables that are often tested for, and give insight 
into the conditioning status of the athlete. LT is a widely-accepted biomarker which is indicative 
of athletic performance (28), and has shown to be the determining factor in the intensity which 
marathon runners perform at (29). Powers et al. found that endurance performance and VT have 
a strong correlation, indicating the use of VT in athletic training contexts (30). In a cycling 
context, Amann et al. also found the VT to be a good indicator of performance, further 
supporting the value of determining VT (19). Seeing as closed circuit indirect calorimetry is 
needed to directly measure VT and measurement of LT is a generally invasive procedure, the 
traditional methods of detecting the anaerobic threshold are uncomfortable procedures for the 
subject and can be costly for the practitioner. The ability to use HRVT rather than blood draws or 
metabolic carts to assess VT poses benefits for all parties.  
 
Heart rate variability threshold testing is a relatively novel procedure, and has not been 
extensively conducted in the literature in all exercise modalities. Generally, HRVT experiments 
are conducted via means of cycle ergometer (31, 32, 33). Several studies have examined HRVT 
using other alternative exercise protocols, but very few have been strictly running protocols. 
Dourado et al. collected HRVT data on a group of older individuals (greater than 40 years old) 
during an incremental shuttle test, but the trials were not repeated to ensure reliability (17). 
Mendia-Iztueta et al. conducted a HRVT study designed to mimic the mechanics of cross 
country skiing on a motorized treadmill, but this method was not a running-based protocol (34). 
Paschoal et al. found a correspondence between VT and HRVT in both obese and non-obese pre-
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adolescents, but this study did not assess the repeatability of the HRVT-VT correspondence nor 
do their findings represent healthy young adults (35). Cunha et al. also found high correlation 
between VT and HRVT on a motorized treadmill, but their findings were not repeated to assess 
inter-test reliability (27). This experiment attempted to fill these gaps by assessing the 
repeatability of HRVT tests on a treadmill. The use of HRVT to assess LT and VT on a 
motorized treadmill is a noninvasive procedure that minimizes subject discomfort while also 
giving additional insight into their sympathetic/parasympathetic regulation. A treadmill 
procedure is the ideal modality to determine this with, seeing as most individuals are more 
familiarized with walking mechanics than they are with cycling mechanics, providing more 
accurate and applicable results. The purpose of this study was to determine whether HRVT 
occurs at the same workload, VO2, VE, and HR in the same subject on different days using a 
motorized treadmill based maximal exercise test. This study also aimed to determine whether 
there is a relationship between the workloads, VO2 values, HR, and VE at which HRVT and VT 
occur using a treadmill modality, as their relationship has been demonstrated in cycling contexts.  
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Chapter II 
Methodology 
Subjects 
10 healthy males age 19-21 from the James Madison University and Rockingham county 
area were recruited for this study. Only males were recruited to exclude possible bias induced 
from skewed HRV data because of the female menstrual cycle (24). Exclusion criteria for 
participation included musculoskeletal, metabolic, and cardiovascular disorders. Additional 
exclusion criteria included regular use of any medication, due to the potential impact on heart 
rate or HRV. Subjects were recruited by word of mouth.  Subjects were instructed to abstain 
from caffeine and food for 12 and 4 hours prior to the trial, respectively.  
Testing Procedure 
The height and weight of each subject was recorded prior to the exercise testing 
procedures. Each individual participated in two maximal graded exercise tests with a minimum 
of 48 hours between each trial. Each individual completed both of their respective trials at the 
same time of day as to avoid diurnal variations of HRV. A standardized treadmill protocol with 3 
minute stages was used for each graded exercise test. Heart rate was measured continuously for 
the entirety of each exercise trial. Each subject progressed through the stages of the protocol until 
volitional fatigue was reached and the subject willfully terminated the trial (36). A metabolic 
measurement system utilizing a high efficiency mixing chamber (TrueOne 2400, Parvo Medics, 
Sandy UT) was used to measure expired CO2 per minute (VCO2) and consumed O2 per minute 
(VO2). Expired gases were also used to determine VT, which was evaluated as the graphical 
point where VCO2 increases disproportionately to VO2, as assessed automatically by the PARVO 
metabolic cart.  Heart rate and R-R data were measured continuously throughout each test with a 
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polar v800 watch (Polar Electro Inc., Lake Success, NY).  After each test, R-R data was 
downloaded to a computer, and analyzed for HRV variables via Kubios HRV software (Version 
3.0, Kuopio, Finland). 
HRVT measurement 
For each trial, the RMSSD of each respective intensity was plotted for the last two 
minutes of HRV data of each stage of the protocol, and visual inspection was used to determine 
HRVT. The intensity at which there was no significant decline in HRV in subsequent intensities 
was assumed to be the HRVT. This inflection point was identified by two separate evaluators to 
avoid bias in the case of ambiguity. If the two evaluators disagreed on the inflection point, a third 
investigator decided which of the two proposed points was to be considered HRVT.  
VT Measurement 
VT was determined automatically using the proprietary software of the Parvo metabolic 
system using a V-slope method. 
Statistical Analysis 
To determine the repeatability of the HRVT across the treadmill trials, as well as to 
assess the relationship between the HRVT and the VT, paired sample t-tests were used to test 
mean difference in the VO2 at which the HRVT and the VT occurs.  
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Chapter 3 
Manuscript 
Repeatability of Heart Rate Variability Threshold During Treadmill Exercise 
Purpose: Heart rate variability threshold (HRVT) is a clinical parameter used to gain insight into 
autonomic balance. Various studies have validated the use of cycle ergometers in determining 
HRVT, although the literature lacks evidence that treadmill use is a viable means of determining 
this threshold. We examined the repeatability of HRVT occurrence using standard deviation of 
normal R-R intervals (SDNN), root mean square of successive differences of continuous R-R 
intervals (RMSSD), and standard deviation of instantaneous beat intervals (SD1) in college aged 
males using treadmill exercise to see if this is a reliable method of threshold determination. 
Methods: Ten healthy, college-aged males underwent two treadmill max tests while heart rate 
and ventilation data was obtained using a polar V-800 watch and a PARVO metabolic cart, 
respectively. Paired t-tests were used to compare consistency of average HRVT and VT 
occurrence between trials, and to find agreement of HRVT and VT occurrence together within 
trials. 
Results: There was no difference between SDNN, RMSSD, SD1, or VT occurrence between 
trials one and two. There a significant difference between RMSSD and VT and SD1 and VT (P = 
0.003 and 0.002, respectively), however there was agreement between SDNN and VT (P = 0.06).  
Conclusion:  Treadmill modality is a reliable method of finding HRVT in a population of 
healthy young males. HRVT and VT does not correspond on a treadmill as it has been reported 
to with cycle ergometry.  
 
 
Keywords: Heart rate variability threshold, treadmill, reliability 
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Introduction  
Heart rate variability (HRV) is a biomarker that can be used in athletic and clinical 
settings. HRV involves analysis of the inter-beat variability to give insight into an individual’s 
autonomic input, with sympathetic tone leading to decreased HRV, and vagal tone leading to the 
opposite (1). Accordingly, HRV is generally high at rest with healthy individuals, and decreases 
with exercise intensity due to vagal withdraw and increased sympathetic input (1). As exercise 
intensity increases and HRV decreases, a threshold is eventually met where inter-beat variability 
no longer decreases with increasing exercise intensity. This is known as the heart rate variability 
threshold (HRVT) and has been shown to occur at approximately the same intensity as lactate 
threshold (LT) and ventilatory threshold (VT) (2). Ventilatory threshold is the intensity at which 
ventilation increases disproportionately to oxygen consumption (VO2) (3).  At this intensity, the 
bicarbonate buffering system is generating more CO2 by neutralizing exercise-provoked H+. 
This induces hypercapnia, which increases VE but not VO2, an intensity that is reached at around 
60% of VO2 for untrained individuals (4, 5). VT is a threshold commonly used in clinical and 
research settings to give insight into conditioning status. This is supported by the work of Powers 
et. al showing that ventilatory threshold is associated with better running performance in trained 
men (21). Similar work by Amann et. al further validate the value of VT, showing that it is a 
better predictive tool than LT when considering average wattage in a cycling time trial (3). 
HRVT is a non-invasive procedure which, being linked to the other thresholds previously 
mentioned, may be a proxy for VT and LT, which require more resources and subject discomfort 
to collect.  
 
  xvii 
The process of acquiring HRVT generally requires the subject to undergo a graded 
maximal exercise test. HRVT has primarily been tested during cycle ergometry (6, 7, 8). 
However various other modalities such as incremental shuttle tests, and mock-cross country 
skiing on a treadmill have been employed (1, 9). To our knowledge, the only prior study that 
used treadmill exercise to assess HRVT was used to detect HRVT in obese and non-obese 
adolescents. This study found that the HRVT occurred at a higher relative VO2 in non-obese 
adolescents, although these results were not assessed for repeatability and are not representative 
of the general population (10). There is a lack of information regarding the reliability of treadmill 
use for HRVT detection, a gap that this study aims to fill. Although ergometer use is verified and 
frequently used for HRVT detection, this modality may introduce bias. Cycle ergometry 
generally leads to lower VO2max values due to local fatigue induced by decreased muscle mass, 
and most subjects are generally more comfortable walking or running than on a stationary bike 
(27, 12).  
 
HRVT is known to be a valuable tool due to its previously mentioned relationship with 
VT and LT. As a result of this relationship, HRVT can be used to give indirect insight to these 
thresholds; a much more cost efficient method if metabolic carts and lactate analyzers are not 
accessible. Ideally, the means of detecting the threshold should be a motion that is not new to the 
individual, and most subjects will be comfortable walking or running. Therefore, the primary 
purpose of this study was to examine the within-subject repeatability of HRVT detection on a 
treadmill.  A secondary purpose was to examine the relationship of the HRVT to the VT, to 
determine if they occur at the same exercise intensity.  
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Materials and Methods 
Subjects 
10 healthy males from the James Madison University community were recruited to 
undergo 2 maximal exercise tests (table 1). Females were excluded to avoid bias due to the 
menstrual cycle’s effect on HRV (11). Exclusion criteria included metabolic and cardiovascular 
disorders and regular use of medication due to their effect on HRV (13, 14, 15). Individuals with 
musculoskeletal disorders were also excluded because these individuals may be physically 
limited and unable to complete a true max test via treadmill modality. 
Testing Procedure 
Subject demographics were recorded for each individual (height, weight, age). Subject 
height was measured from standing using a stadiometer, and weight was recorded in kg using a 
Pelouze model 4040 scale. Each subject underwent two maximal graded exercise tests, separated 
by a minimum of 48 hours. To avoid diurnal variation of HRV, the time of day each subject 
completed their test was also kept constant. A standardized treadmill protocol with 3 minute 
stages was used for each graded exercise test.  Ventilation data (expired O2 and CO2) was 
collected through the entirety of the test, and was later used to derive VT. Heart rate and R-R 
data was also monitored through the entirety of each test using a polar RS800CX watch (Polar 
Electro Inc., Lake Success, NY). Kubios HRV software was used to analyze the HRV data 
(Version 3.0, Kuopio, Finland). 
HRVT determination 
For each trial, three HRV parameters were used: standard deviation of normal R-R 
intervals (SDNN), root mean square of successive differences of continuous R-R intervals 
(RMSSD), and standard deviation of instantaneous beat intervals (SD1). 
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Three graphs were generated for each test (6 total per subject), each of which showed the 
respective parameter in the last minute of each stage of the max protocol, which was presumed to 
be steady state. These graphs were interpreted by two separate individuals, each of which 
selected which point they believed to represent HRVT. If the interpreters did not select the same 
point, a third individual determined which of the two points was to be identified as the HRVT. If 
the three individuals all selected different points for VT or on of the HRVT indices, the subject’s 
data was not used for the analysis in question.  
VT Measurement 
The VT of each trial was detected automatically by a PARVO metabolic cart using the V-
slope method (23).   
Statistical Analysis 
Paired t-tests were used to test mean difference in the intensity at which HRVT (as 
indicated by RMSSD, SD1, and SDNN) and VT occurred. When comparing the incidence of 
HRVT parameters, averaged values from trial one were compared to averaged values of trial 
two. When comparing the incidence of HRVT parameters to the incidence of VT, HRVT values 
of trial one and two were averaged for each respective variable, and then compared. Bland-
Altman plots were utilized to evaluate agreement between HRVT values (RMSSD, SDNN, and 
SD1 derived) between each TM trial, and to evaluate agreement between HRVT and VT.  
Results 
Trial 1 to Trial 2 Comparison 
Maximal testing information is presented in Table 2.  There were no differences in 
VO2max, VE/VCO2 slope, or respiratory exchange ratio between trial 1 and trial 2 (P = 0.24, 0.56, 
and 0.32, respectively). Maximal heart rate was significantly lower in trial 2 compared to trial 1 
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(P = 0.03). Several HRVT graphs were omitted from analysis due to investigator disagreement of 
inflection points. Data from two individuals was omitted for RMSSD graphs (N=8), data for 
three individuals were omitted for SD1 analysis (N=7), while no data was omitted for SDNN 
analysis (table 3). No significant differences were found between the VO2 at which the HRVT 
occurred for RMSSD (P = 0.37), SDNN (P = 0.55), and SD1 (P = 0.83) between trials 1 and 2 
(table 3).  Additionally, there was no significant difference in the VO2 at which VT occurred 
between trials 1 and 2 (P = 0.33). Bland-Altman analysis revealed good agreement between trials 
for the HRVT derived from SD1 (Figure 1), SDNN (Figure 2), and RMSSD (Figure 3).  Bland-
Altman analysis also showed good agreement between trials for the VO2 at which VT occurred 
(Figure 4). 
HRVT to VT comparison 
Paired t-tests revealed that the VO2 at which the HRVT occurred for RMSSD and SD1 
was lower than the VO2 at which the VT occurred, while the VO2 at which the HRVT occurred 
for SDNN did not differ from the VT (P = 0.06) (Table 4). Bland-Altman analysis revealed 
similar findings in that the RMSSD (Figure 5) and SD1 (Figure 6) comparisons to VT did not 
show agreement (P = 0.003 and 0.002 for RMSSD and SD1, respectively), while the SDNN to 
VT comparison (Figure 7) did show agreement (P = 0.06).  
Discussion 
The results obtained from this study demonstrate there was no difference in HRVT 
occurrence between trials one and two. Previously, HRVT detection has been determined 
primarily by means of cycle ergometry (6, 7, 8). Demonstrating that this threshold can be 
consistently detected by treadmill testing is a finding that may allow HRVT detection to be a 
more accessible parameter to those without the resources to conduct a cycle ergometer max test. 
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The disparities between RMSSD vs. VT and SD1 vs. VT disagrees with previous 
literature where HRVT and VT were demonstrated to occur at same intensity (2,19,20, 2).  A 
number of factors may explain the contradictory findings. For instance, Karapetian et al. 
recruited a subject base that was mostly female (15 females, 9 males), while our study examined 
only males (2). It is possible that the influence of the female menstrual cycle on HRV may have 
introduced some bias in their work, since it has been shown that the autonomic balance which 
dictates HRV can be shifted dependent on the phase of the menstrual cycle, which Karapetian’s 
study did not control for (2, 11). Additionally, they used a visually determined V-slope method 
of identifying VT occurrence, while our study used a PARVO metabolic cart to automatically 
detect VT, possibly altering the identification of the threshold (2).  
 
Finally, the group of subjects recruited for our study was relatively trained, having a 
mean VO2max of 53.6 mL/kg/min, which is classified as being between the 85th and 90th 
percentile of age matched VO2 values (15). The males used in Karapetian’s study had an average 
VO2max of 38.8 mL/kg/min, which falls between the 20th and 25th percentile (2,15). This is a 
similar case for the results obtained in Anosov’s work, which found that the HRVT and VT 
occurred at the same point in a group of 13 females and 9 males. These individuals were all 
untrained, and were reported to exercise less than four hours per week (19). The detraining of 
these subjects and the mix of males and females in the subject pool may play a role in the 
difference in of results seen in their study and ours in terms of the occurrence of HRVT and VT. 
Finally, Cunha et al. also demonstrated that VT and HRVT occurred at the same intensity in 16 
apparently healthy college aged males (20). In this study, similar methods as the other two 
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previously mentioned studies were employed: a manual V-slope detection method and a group of 
individuals less trained than those used in the current study. The average VO2max of the males in 
Cunha’s study was found to be 48.3 mL/kg/min, which the ACSM guidelines categorizes to be 
between the 70th-75th percentile (20,15).  
 
We suspect that the most likely explanation for the uncoupling of HRVT and VT is the 
training status/fitness of the current sample. While there no established mechanism for this, HRV 
is used to give insight into autonomic input at rest, and is widely accepted as a trainable 
phenomenon (24, 25, 26). While no previous literature has examined the trainability of HRVT, 
which is the point at which HRV ceases with increasing exercise intensity, vagal input is totally 
withdrawn at roughly 60% exercise intensity, and increasing heart rate after this point is the 
result of increased sympathetic input which would also induce a change in HRV (1). Our results 
suggest that although HRV is a trainable phenomenon, HRVT may not be. Given that HRV 
adaptations to training indicates a shift in autonomic balance, it would be reasonable to assume 
that this training induced shift in autonomic balance would in turn influence the occurrence of 
HRVT. This may not be the case however, seeing as we demonstrate HRVT occurred at a lower 
intensity than VT, which was most likely trained to a higher intensity. The average HRVT and 
VT of Cunha’s work was 56±11% and 53±7% of VO2max, respectively, using SD1 to assess 
HRVT (20). Their HRVT results are consistent with the results of this study, where SD1 was 
detected at roughly 54±9% of VO2max (table 3). However, our findings differ in terms of VT 
occurrence, where VT was detected at roughly 68±16% of VO2max (table 3). This further supports 
that HRVT may not be a trainable parameter, and our cohort may have had higher VT 
occurrences compared to groups in similar studies. Seeing as HRVT is the point at which no 
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HRV is observed with increased intensity, and it is known that sympathetic input is still 
increasing past the HRVT to increase heart rate, it may be plausible that HRVT is the result of 
the structure of the pacemaker cells themselves, and that training does not alter their makeup in a 
way that could be reflected via HRVT. To date, no mechanism has been proposed to explain the 
occurrence of HRVT, so further studies are necessary to test this hypothesis. We propose that a 
training intervention be administered to a subject demographic similar to that used in this study 
to determine the trainability of HRVT vs. the trainability of VT.  
 
No difference was found between the VO2max achieved between trial one and two, as 
expected based on previous studies (12). Maximal heart rate was found to be significantly 
different between trials one and two (P < .05). However, it has been predetermined that max 
heart rate can vary by 10 beats per minute, and our average max heart rate for trial 1 and 2 falls 
within this range (16). No significant difference was found between the VE/VCO2 slope nor the 
VT between trials one and two, further indicating that there was no change in the training status 
of these individuals between trials (17, 18).  Possible limitations to this study include the method 
of VT detection previously mentioned and the low number of subjects recruited. Some analysis 
had to be completed on as little as seven subjects, which is not optimal when attempting to 
represent a population.  
 
To summarize, treadmill modality is a reliable measure that can detect HRVT in a group 
of college aged males. However, it appears as though HRVT and VT do not occur at the same 
intensity, an observation that cannot be attributed to any one variable. The exercise modality 
used to detect HRVT may be the cause of observation, or this may be the effect of having a 
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trained population. Further work is needed to differentiate between these two explanations. 
Future work should be directed towards investigating the degree of trainability of HRVT, and the 
effect of exercise modality on the occurrence of HRVT and VT.  
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Table 1. Subject Characteristics.  
Characteristic Mean ± Standard Deviation 
Age (year) 20.5±.7 
Height (cm)  174.1±7.1 
Weight (kg)  78.4±6.5 
BMI (kg/m2) 25.9±2.2 
VO2 max 
(mL/kg/min) 
(n=10) 
53.6±6.1 
BMI = body mass index; VO2 = oxygen consumption rate 
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Table 2. Maximal Exercise Test Data  
 Trial 1 (Average ± Standard 
Deviation) 
Trial 2 (Average ± Standard 
Deviation) 
P Value 
HRmax (bpm) 191.1±8.7 187.8±9.3 .03* 
VO2max 
(mL/kg/min) 
53.3±6.2 54.1±6.4 0.24 
VE/VCO2 slope 29.3±4.6 29.0±3.9 0.56 
RERmax (L/min) 1.1±.04 1.1±.05 0.32 
*Correlation is significant (p < 0.05) 
HR = heart rate; VO2 = oxygen consumption rate; VE = ventilitory equivalent; VCO2 = carbon 
dioxide production; RER = respiratory exchange ratio 
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Table 3. HRVT and VT data for Trials 1 and 2  
 
 Trial 1  Trial 2  P value 
RMSSD HRVT 
(L/min)  2.4 ± .6 2.2 ± 0.3 0.37 
RMSSD HRVT 
(% max) (n=8) 58.5 ± 10.3 53.5 ± 8.6 0.3 
SDNN HRVT 
(L/min)  2.8 ± 0.5 2.7 ± 0.5 0.55 
SDNN HRVT 
(% max)  69.0 ± 9.8 65.9 ± 7.4 0.48 
SD1 HRVT 
(L/min)  2.4 ± 0.6 2.3 ± 0.6 0.83 
SD1 HRVT (% 
max)  55.5 ± 9.8 53 ± 9.1 0.72 
VT (L/min)  3.0 ± .3 3.1 ± .3 0.33 
VT (% max) 68.0 ± 18 69.3 ± 14.4 0.86 
RMSSD = root mean square of successive differences of continuous R-R intervals; HRVT = 
heart rate variability threshold; SDNN = standard deviation of normal R-R intervals; SD1 = 
standard deviation of instantaneous beat intervals; VT = ventilatory threshold 
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Table 4. HRVT and VT Comparison Data 
Pair Parameter Mean P-Value 
RMSSD vs. 
VT 
Mean RMSSD  2.3 ±.3 0.003* 
Mean VT 3.0±.3 
SDNN vs. 
VT 
Mean SDNN  2.8±.5 0.06 
Mean VT 
 
3.0±.3 
SD1 vs. VT Mean SD1 2.3±.5 0.002* 
Mean VT  3.1±.3 
RMSSD = root mean square of successive differences of continuous R-R intervals; SDNN = 
standard deviation of normal R-R intervals; SD1 = standard deviation of instantaneous beat 
intervals; VT = ventilatory threshold 
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Figure 1. Bland-Altman displaying the average SD1 occurrence between trials one and two 
versus the difference between the two trials for each subject. Dashed lines represent 1.96 
standard deviations from the mean indicated by the solid black line. 
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Figure 2. Bland-Altman displaying the average SDNN occurrence between trials one and two 
versus the difference between the two trials for each subject. Dashed lines represent 1.96 
standard deviations from the mean indicated by the solid black line. 
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Figure 3. Bland-Altman displaying the average RMSSD occurrence between trials one and two 
versus the difference between the two trials for each subject. Dashed lines represent 1.96 
standard deviations from the mean indicated by the solid black line. 
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Figure 4. Bland-Altman displaying the average VT occurrence between trials one and two 
versus the difference between the two trials for each subject. Dashed lines represent 1.96 
standard deviations from the mean indicated by the solid black line. 
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Figure 5. Bland-Altman displaying the average intensities of RMSSD and VT occurrence 
between trials one and two versus the difference between the two trials for each subject. Dashed 
lines represent 1.96 standard deviations from the mean indicated by the solid black line.   
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Figure 6. Bland-Altman displaying the average intensities of SD1 and VT occurrence between 
trials one and two versus the difference between the two trials for each subject. Dashed lines 
represent 1.96 standard deviations from the mean indicated by the solid black line. 
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Figure 7. Bland-Altman displaying the average intensities of SDNN and VT occurrence between 
trials one and two versus the difference between the two trials for each subject. Dashed lines 
represent 1.96 standard deviations from the mean indicated by the solid black line. 
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James Madison University 
Department of Kinesiology 
Informed Consent 
  
Purpose 
  
You are being asked to volunteer for a research study conducted by Dr. Trent Hargens and Shane 
Chambers from James Madison University entitled, “Heart Rate Variability Threshold 
Determination Across Exercise Trials”. 
  
The goal of this study is to examine whether a method for non-invasively measuring a measure 
of physiological function is repeatable on multiple days while exercising on a treadmill.  
  
Experimental Procedures 
  
You will be asked to visit the Human Performance Laboratory (HPL) in Godwin Hall 2 times 
over the course of about 1 – 2 weeks.  Your total time commitment for participation in this study 
will be about 2 hours (each visit about an hour). 
  
Upon completion of this informed consent, you will be asked to complete 2 short questionnaires, 
1 that asks about your ability to participate in physical activity, and 1 that asks about your current 
level of physical activity participation.  Each of these questionnaires should take about 5 minutes 
to complete.  
  
You will then have your height and weight measured.  Upon completion of this, you will be 
asked to complete a maximal treadmill exercise test.  During the test, researchers will monitor 
your heart rate, blood pressure and your perceived exertion to the workload you will be 
doing.  You will wear a strap on your skin on your torso, to allow us to monitor your heart 
rate.  During the test, you will breathe only through a mouthpiece, with your nose clamped off, 
so that we can measure the amount of oxygen you use during exercise.  The treadmill will start 
with a very slow speed and little grade, and will steadily increase in speed and grade every three 
minutes throughout the test.  At the end of the test, it should be a best effort on your part.  It may 
be as hard as any exercise you remember doing.  At the end of each three minute stage, you will 
then dismount the treadmill and a drop of blood will be obtained through a finger lancet and 
analyzed for blood lactate. The exercise test will last about 12 – 18 minutes, requiring 4 - 6 blood 
samples.  Prior to your arrival to the HPL that day, you will be asked to refrain from eating for 4 
hours prior to your arrival, and to avoid caffeine and alcohol for that time period as well. 
  
Upon completion of this visit, you will be asked to return to the HPL an additional time, a 
minimum of 48 hours later, and at the same time of day as the first visit.  The remaining visit will 
consist of an additional maximal treadmill test, identical to your visit 1. 
  
Risks 
  
There is a risk of abnormal changes during the maximal exercise tests.  These changes may 
include abnormal blood pressure, fainting, heart rhythm disorders, stroke, heart attack, and 
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death.  The chance of serious heart problems during maximal exercise among adults is very small 
(less than 1/10,000 maximal exercise tests).  Every effort will be made to minimize risks of an 
abnormal response by reviewing you health history and providing adequate supervision of the 
exercise test.  All staff are certified by the American Heart Association in BLS (Basic Life 
Support), and all tests will be supervised by individuals certified by the American College of 
Sports Medicine.  The risks associated with obtaining small samples of blood via finger-sticks 
are minimal but include bruising and discomfort for 24 to 48 hours and infection. The risk for 
infection is small and will be minimized by the use of sterile methods, including the use of sterile 
alcohol pads, sterile gauze, and band-aids. 
  
Benefits 
  
Participation may include knowledge about your health status.  You will receive information on 
your cardiovascular fitness. 
  
Inquiries 
  
If you have any questions or concerns or you would like to receive a copy of the final aggregate 
results of this study, please contact Dr. Trent Hargens at hargenta@jmu.edu or (540) 568-5844. 
  
Questions about Your Rights as a Research Subject 
Dr. David Cockley                                                                                       
Chair, Institutional Review Board                                                    
James Madison University                                                                    
(540) 568-2834                                                                                           
cocklede@jmu.edu                                                                                  
  
Confidentiality 
  
All data and results will be kept confidential. You will be assigned an identification number and 
a pseudonym in place of your real name. At no time will your name be identified with your 
individual data. The researcher retains the right to use and publish non-identifiable data. All 
paper data will be kept secured in a locked cabinet in a locked office. All electronic data will be 
kept on a password-protected computer in encrypted file folders.  Final aggregate results will be 
made available to participants upon request. 
  
Freedom of Consent 
  
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you 
choose to participate, you can withdraw at any time without consequences of any kind. 
  
I have read this consent form and I understand what is being requested of me as a participant in 
this study.  I freely consent to participate.  I have been given satisfactory answers to my 
questions.  The investigator provided me with a copy of this form I requested it.  I certify that I 
am at least 18 years of age.  By clicking "Yes" to the question below and submitting this 
confidential online survey, I am consenting to participate in this research. 
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Do you provide consent to participate in the research study entitled, "Heart Rate Variability 
Threshold Determination Across Exercise Trials"? 
 
o Yes 
o No 
 
Please enter your name here 
 
 
 
Please enter today's date 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as part of 
their everyday lives. The questions will ask you about the time you spent being physically active 
in the last 7 days. Please answer each question even if you do not consider yourself to be an 
active person. Please think about the activities you do at work, as part of your house and yard 
work, to get from place to place, and in your spare time for recreation, exercise or sport. 
 
Please input your name of a pet you've had and the name of the street you grew up on 
(example:  Rover Main) 
 
 
Think about all the vigorous activities that you did in the last 7 days. Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much harder than 
normal. Think only about those physical activities that you did for at least 10 minutes at a time. 
 
During the last 7 days, on how many days did you do vigorous physical activities like heavy 
lifting, digging, aerobics, or fast bicycling? (enter only the number of days in the blank) 
 
 
How much time did you usually spend doing vigorous physical activities on one of those days? 
(only enter the number into each blank.  If you don't know/are unsure, leave blank) 
 
Hours Per Day: __________________ 
Minutes Per Day: ________________ 
Think about all the moderate activities that you did in the last 7 days. Moderate activities refer 
to activities that take moderate physical effort and make you breathe somewhat harder than 
normal. Think only about those physical activities that you did for at least 10 minutes at a time. 
 
During the last 7 days, on how many days did you do moderate physical activities like carrying 
light loads, bicycling at a regular pace, or doubles tennis?  Do not include walking.  (Only enter 
the number into the blank) 
 
 
How much time did you usually spend doing moderate physical activities on one of those days? 
(only enter the number into each blank.  If you don't know/are unsure, leave blank) 
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Hours Per Day: __________________ 
Minutes Per Day: ________________ 
Think about the time you spent walking in the last 7 days.  The includes at work and at home, 
walking to travel from palce to place, and any other walking that yo might do solely for 
recreation, sport, exercise, or leisure. 
 
During the last 7 days, on how many days did you walk for at least 10 minutes at a time?  (Only 
enter the number into the blank) 
 
 
How much time did you usually spend doing walking physical activities on one of those days? 
(only enter the number into each blank.  If you don't know/are unsure, leave blank) 
 
Hours Per Day: __________________ 
Minutes Per Day: ________________ 
The last question is about the time you spent sitting on weekday during the last 7 days.  Include 
time spent at work, at home, while doing course work and during leisure time.  This may include 
time spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch television. 
 
During the last 7 days, how much time did you spend sitting on a week day? (only enter the 
number into each blank.  If you don't know/are unsure, leave blank) 
 
Hours Per Day: __________________ 
Minutes Per Day: ________________ 
 
We thank you for your time spent taking this survey.  
Your response has been recorded. 
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Physical Activity Readiness Questionnaire (PAR-Q) 
 
Regular physical activity is fun and healthy, and increasingly more people are starting to become 
more active every day. Being more active is very safe for most people. However, some people 
should check with your doctor before you start. 
  
If you are planning to become much more physically active than you are now, start by answering 
the seven questions in the box below. If you are between the ages of 15 and 69, the PAR-Q will 
tell you if you should check with your doctor before you start. If you are over 69 years of age, 
and you are not used to being very active, check with your doctor. 
 
Common sense is your best guide when you answer these questions. Please read the questions 
carefully and answer each one honestly: check YES or NO 
Question Yes No 
Has your doctor ever said that 
you have a heart condition 
and that you should only do 
physical activity 
recommended by a doctor? 
  
Do you feel pain in your 
chest when you do physical 
activity? 
  
In the past month, have you 
had a chest pain when you 
were not doing physical 
activity? 
  
Do you lose your balance 
because of dizziness or do 
you ever lose consciousness? 
  
Do you have a bone or joint 
problem (for example, back, 
knee, or hip) that could be 
made worse by a change in 
your physical activity? 
  
Is your doctor currently 
prescribing drugs (for 
example, water pills) for your 
blood pressure or heart 
condition 
  
Do you have diabetes or a 
thyroid condition? 
  
Do you know of any other 
reasons why you should not 
do physical activity? 
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Standardized Treadmill Protocol 
 
 
 
 
 
 
 
 
 
 
 
  xlviii 
Stage Minutes Speed (mph) Grade (%) METs 
1 1-3 3.0 0 3.3 
2 4-6 3.5 3.5 5.4 
3 7-9 3.9 6.5 7.5 
4 10-12 5.5 0.5 9.6 
5 13-15 6.0 3.5 11.6 
6 15-18 6.5 6.0 13.6 
7 19-22 6.8 9.0 15.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  xlix 
Bibliography 
1. DiFrancesco, D. (1993). Pacemaker mechanisms in cardiac tissue. Annual review of 
physiology, 55(1), 455-472. 
2. Smith, D. L., & Fernhall, B. (2011). Advanced cardiovascular exercise physiology. Human 
Kinetics. 
3. Stauss, H. M. (2003). Heart rate variability. American Journal of Physiology-Regulatory, 
Integrative and Comparative Physiology, 285(5), R927-R931. 
4. Yasuma, F., & Hayano, J. I. (2004). Respiratory sinus arrhythmia: why does the heartbeat 
synchronize with respiratory rhythm?. Chest Journal, 125(2), 683-690. 
5. Task Force of the European Society of Cardiology. (1996). Heart rate variability standards of 
measurement, physiological interpretation, and clinical use. Eur heart J, 17, 354-381. 
6. Saul, J. P. (1990). Beat-to-beat variations of heart rate reflect modulation of cardiac autonomic 
outflow. Physiology, 5(1), 32-37. 
7. Bonnemeier, H., Wiegand, U. K., Brandes, A., Kluge, N., Katus, H. A., Richardt, G., & 
Potratz, J. (2003). Circadian profile of cardiac autonomic nervous modulation in healthy 
subjects. Journal of cardiovascular electrophysiology, 14(8), 791-799. 
8. Malpas, S. C., & Purdie, G. L. (1990). Circadian variation of heart rate variability. 
Cardiovascular research, 24(3), 210-213. 
9. Thayer, J. F., Åhs, F., Fredrikson, M., Sollers, J. J., & Wager, T. D. (2012). A meta-analysis of 
heart rate variability and neuroimaging studies: implications for heart rate variability as a 
marker of stress and health. Neuroscience & Biobehavioral Reviews, 36(2), 747-756. 
10. Dikecligil, G. N., & Mujica-Parodi, L. R. (2010). Ambulatory and challenge-associated heart 
rate variability measures predict cardiac responses to real-world acute emotional stress. 
Biological psychiatry, 67(12), 1185-1190. 
11. Tsuji, H., Larson, M. G., Venditti, F. J., Manders, E. S., Evans, J. C., Feldman, C. L., & 
Levy, D. (1996). Impact of reduced heart rate variability on risk for cardiac events. 
Circulation, 94(11), 2850-2855. 
12. Tsuji, H., Venditti, F. J., Manders, E. S., Evans, J. C., Larson, M. G., Feldman, C. L., & 
Levy, D. (1994). Reduced heart rate variability and mortality risk in an elderly cohort. 
The Framingham Heart Study. Circulation, 90(2), 878-883. 
13. Umetani, K., Singer, D. H., McCraty, R., & Atkinson, M. (1998). Twenty-four hour time 
domain heart rate variability and heart rate: relations to age and gender over nine 
decades. Journal of the American College of Cardiology, 31(3), 593-601. 
14. Seals, D. R., & Chase, P. B. (1989). Influence of physical training on heart rate variability 
and baroreflex circulatory control. Journal of Applied Physiology, 66(4), 1886-1895. 
15. Bär, K. J., Herbsleb, M., Schumann, A., de la Cruz, F., Gabriel, H. W., & Wagner, G. (2016). 
Hippocampal-Brainstem Connectivity Associated with Vagal Modulation after an Intense 
Exercise Intervention in Healthy Men. Frontiers in neuroscience, 10. 
16. Stein, P. K., Ehsani, A. A., Domitrovich, P. P., Kleiger, R. E., & Rottman, J. N. (1999). 
Effect of exercise training on heart rate variability in healthy older adults. American heart 
journal, 138(3), 567-576. 
17. Dourado, V. Z., & Guerra, R. L. F. (2013). Reliability and validity of heart rate variability 
threshold assessment during an incremental shuttle-walk test in middle-aged and older 
adults. Brazilian Journal of Medical and Biological Research, 46(2), 194-199. 
  l 
18. Karapetian, G. K., Engels, H. J., & Gretebeck, R. J. (2008). Use of heart rate variability to 
estimate LT and VT. International journal of sports medicine, 29(08), 652-657. 
19. Amann, M., Subudhi, A. W., & Foster, C. (2006). Predictive validity of ventilatory and 
lactate thresholds for cycling time trial performance. Scandinavian journal of medicine & 
science in sports, 16(1), 27-34. 
20. Beaver, W. L., Wasserman, K. A. R. L. M. A. N., & Whipp, B. J. (1986). A new method for 
detecting anaerobic threshold by gas exchange. Journal of applied physiology, 60(6), 
2020-2027. 
21. Simon, J. O. S. H. U. A., Young, J. L., Blood, D. K., Segal, K. R., Case, R. B., & Gutin, B. 
E. R. N. A. R. D. (1986). Plasma lactate and ventilation thresholds in trained and 
untrained cyclists. Journal of Applied Physiology, 60(3), 777-781. 
22. Galbo, H., Holst, J. J., & Christensen, N. J. (1975). Glucagon and plasma catecholamine 
responses to graded and prolonged exercise in man. Journal of applied physiology, 38(1), 
70-76. 
23. Hems, D. A., Rodrigues, L. M., & Whitton, P. D. (1976). Glycogen phosphorylase, glucose 
output and vasoconstriction in the perfused rat liver. Concentration-dependence of 
actions of adrenaline, vasopressin and angiotensin II. Biochemical Journal, 160(2), 367-
374.  
24. Chang, A. J., Ortega, F. E., Riegler, J., Madison, D. V., & Krasnow, M. A. (2015). Oxygen 
regulation of breathing through an olfactory receptor activated by lactate. Nature, 
527(7577), 240-244. 
25. Hardarson, T., Skarphedinsson, J. O., & Sveinsson, T. (1998). Importance of the lactate 
anion in control of breathing. Journal of Applied Physiology, 84(2), 411-416. 
26. Anosov, O., Patzak, A., Kononovich, Y., & Persson, P. B. (2000). High-frequency 
oscillations of the heart rate during ramp load reflect the human anaerobic threshold. 
European journal of applied physiology, 83(4-5), 388-394. 
27. Cunha, F. A., Montenegro, R. A., Midgley, A. W., Vasconcellos, F., Soares, P. P., & 
Farinatti, P. (2014). Influence of exercise modality on agreement between gas exchange 
and heart rate variability thresholds. Brazilian Journal of Medical and Biological 
Research, 47(8), 706-714. 
28. Faude, O., Kindermann, W., & Meyer, T. (2009). Lactate threshold concepts. Sports 
medicine, 39(6), 469-490. 
29. Farrell, P. A., Wilmore, J. H., Coyle, E. F., Billing, J. E., & Costill, D. L. (1993). Plasma 
lactate accumulation and distance running performance. 1979. 
30. Powers, S. K., Dodd, S., Deason, R., Byrd, R., & Mcknight, T. (1983). Ventilatory threshold, 
running economy and distance running performance of trained athletes. Research 
Quarterly for Exercise and Sport, 54(2), 179-182. 
31. Lazoglu, A. H., Glace, B., Gleim, G. W., & Coplan, N. L. (1996). Exercise and heart rate 
variability. American heart journal, 131(4), 825-827. 
32. Sales, M. M., Campbell, C. S. G., Morais, P. K., Ernesto, C., Soares-Caldeira, L. F., Russo, 
P., ... & Simões, H. G. (2011). Noninvasive method to estimate anaerobic threshold in 
individuals with type 2 diabetes. Diabetology & metabolic syndrome, 3(1), 1. 
33. Quinart, S., Mourot, L., Negre, V., Simon-Rigaud, M. L., Nicolet-Guénat, M., Bertrand, A. 
M., ... & Mougin, F. (2014). Ventilatory thresholds determined from HRV: comparison 
of 2 methods in obese adolescents. International journal of sports medicine, 35(03), 203-
208. 
  li 
34. Mendia-Iztueta, I., Monahan, K., Kyröläinen, H., & Hynynen, E. (2016). Assessment of 
Heart Rate Variability Thresholds from Incremental Treadmill Tests in Five Cross-
Country Skiing Techniques. PloS one, 11(1), e0145875. 
35. Paschoal, M. A., & Fontana, C. C. (2011). Method of heart rate variability threshold applied 
in obese and non-obese pre-adolescents. Arquivos brasileiros de cardiologia, 96(6), 450-
456. 
36. Thompson, W. R., Gordon, N. F., & Pescatello, L. S. (2010). ACSM's guidelines for exercise 
testing and prescription. Philadelphia: Lippincott Williams & Wilkins. 
 
